Skip To Main Content

Investors & Media

Company Overview
View All

LyGenesis’s cell therapies are engrafted using endoscopic ultrasound procedure, which is associated with decreased medical risks and costs relative to full organ transplantation. Our pipeline of therapies target a variety of unmet needs, including end stage liver disease, Type 1 diabetes, end stage renal disease, aging, and autoimmune disorder.

LyGenesis Announces Four Peer-Reviewed Publications on its Organ Regeneration Technology

August 27, 2021 - Successful preclinical studies solidify the foundation for its first human clinical trial of a cell-based therapy to regenerate ectopic organs in lymph nodes
Read More

AgeX Therapeutics and LyGenesis Terminate Merger Negotiations

July 23, 2021 - LyGenesis will continue to advance its clinical-stage allogeneic cell therapy for patients with end stage liver disease, and advance its pipeline of preclinical cell therapies enabling pancreas, thymus, and kidney regeneration.
Read More
AgeX and LyGenesis logos

AgeX Therapeutics and LyGenesis to Negotiate Merger Agreement

March 2, 2021 - Merger would create a clinical-stage cell therapy company
Read More
AgeX Therapeutics and LyGenesis logos

LyGenesis Receives FDA Clearance to Begin Phase 2a Trial of its Cell Therapy for Patients with End Stage Liver Disease, and also Closes $11 Million Convertible Debt Financing

December 30, 2020 - LyGenesis, Inc. announced today that the U.S Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application.
Read More

LyGenesis Closes $4 Million Convertible Debt Financing to Begin Clinical Development of its Liver Regeneration Technology

October 21, 2019 - Funds will support a Phase 2a clinical trial for patients with end stage liver disease in 2020
Read More
three men laughing and smiling, leaning on a wall

LyGenesis Closes $3 Million Series A Financing to Advance Its Organ Regeneration Technology to the Clinic

May 19, 2018 - Groundbreaking technology regrows organs inside a patient's own lymph nodes
Read More